BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.610
-0.170 (-9.55%)
At close: Sep 18, 2026, 4:00 PM EDT
1.630
+0.020 (1.24%)
After-hours: Sep 18, 2026, 7:57 PM EDT
BioVie Employees
BioVie had 13 employees as of June 30, 2026. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,701,262
Market Cap
12.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2025 | 13 | -1 | -7.14% | 13 | 0 |
| Jun 30, 2024 | 14 | -4 | -22.22% | 14 | 0 |
| Jun 30, 2023 | 18 | 5 | 38.46% | 18 | 0 |
| Jun 30, 2022 | 13 | 7 | 116.67% | 13 | 0 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Daré Bioscience | 24 |
| BioLineRx | 24 |
| NeuroSense Therapeutics | 17 |
| CalciMedica | 15 |
| AEON Biopharma | 8 |
| MetaVia | 8 |
| Phio Pharmaceuticals | 6 |
BIVI News
- 4 days ago - BioVie Transcript: Study result - Transcripts
- 4 days ago - BioVie Press release: Study result - Filings
- 4 days ago - BioVie Slides: Study result - Filings
- 4 days ago - BioVie announces topline results from ADDRESS-LC trial - TheFly
- 4 days ago - BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - GlobeNewsWire
- 5 days ago - BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid - GlobeNewsWire
- 11 days ago - BioVie Announces Update to Parkinson's Phase 3 Development Program - GlobeNewsWire
- 19 days ago - BioVie completes treatment phase of ADDRESS-LC trial - TheFly